April 8 (Reuters) - BARD1 Life Sciences Ltd BD1.AX :
* BARD1 AND SIENNA CANCER DIAGNOSTICS ANNOUNCE MERGER
* ENTERED INTO A MERGER IMPLEMENTATION AGREEMENT WITH SIENNA CANCER DIAGNOSTICS
* SIENNA SHAREHOLDERS WILL BE OFFERED 13 NEW SHARES IN BARD1 FOR EVERY 5 SHARES IN SIENNA
* UNDER DEAL, VALUES EACH SIENNA SHARE AT $0.061
* DEAL VALUES EACH SIENNA SHARE AT $0.061 PER SHARE & SIENNA AT ABOUT $23.7 MILLION ON FULLY DILUTED BASIS